Abstract Streptococcus dysgalactiae subsp. equisimilis (SDSE) has virulence factors similar to those of Streptococcus pyogenes. Therefore, it causes pharyngitis and severe infections indistinguishable from those caused by the classic pathogen. The objectives of this study were: to know the prevalence of SDSE invasive infections in Argentina, to study the genetic diversity, to determine the presence of virulence genes, to study antibiotic susceptibility and to detect antibiotic resistance genes. Conventional methods of identification were used. Antibiotic susceptibility was determined by the disk diffusion and the agar dilution methods and the E-test. Twenty eight centers from 16 Argentinean cities participated in the study. Twenty three isolates (16 group G and 7 group C) were obtained between July 1 2011 and June 30 2012. Tw o adult patients died (8.7%). Most of the isolates were recovered from blood (60.9%). All isolates carried speJ and ssa genes. stG62647, stG653 and stG840 were the most frequent emm types. Nineteen different PFGE patterns were detected. All isolates were susceptible to penicillin and levofloxacin, 6 (26.1%) showed resistance or reduced susceptibility to erythromycin Resumen Streptococcus dysgalactiae subsp. equisimilis (SDSE) posee factores de virulencia similares a Streptococcus pyogenes y, en consecuencia, produce faringitis e infecciones graves indistinguibles de las generadas por este patógeno clásico. Los objetivos del estudio fueron conocer la prevalencia de SDSE en infecciones invasivas en Argentina, estudiar su diversidad genética, determinar la presencia de genes de virulencia, ensayar su sensibilidad a los antibióti-cos y conocer los genes de resistencia. Se emplearon métodos convencionales de identificación. La sensibilidad se determinó por difusión, Etest y dilución en agar. Participaron 28 centros de 16 ciudades argentinas. Se obtuvieron 23 aislamientos (16 del grupo G y 7 del grupo C) desde el 1-7-2011 hasta el 30-6-2012. Se registraron 2 muertes en adultos (8,7%). La mayoría de los aislamientos fueron obtenidos de sangre (60,9% [O]). La prevalencia anual en la Argentina fue de al menos 23 infecciones invasivas por SDSE y se observó una amplia diversidad genética. Todos los aislamientos presentaron los genes ssa y speJ. Como en otros estudios, la resistencia a macrólidos (26,1%) estuvo asociada, principalmente, al fenotipo MLS B .
Introduction
␤-Hemolytic streptococci are common pathogens that usually cause community-acquired infections.
In general, ␤-hemolytic streptococci isolated from human beings belong to Lancefield groups A, B, C, G, F, or more rarely, to L 18 . Until recently, group A streptococci (GAS, Streptococcus pyogenes) 63 and group B streptococci (GBS, Streptococcus agalactiae) 45, 60 were considered the most important pathogens of this group of microorganisms in clinical settings.
GAS is responsible for a broad spectrum of human infections that result in significant morbidity and mortality, including pharyngitis, scarlet fever, skin and soft tissue infection (SSTI), streptococcal toxic shock syndrome (STSS), septicemia, pneumonia and rarely meningitis 13 . It is estimated that severe GAS diseases lead to more than 500,000 deaths each year via infections such as acute rheumatic fever, rheumatic heart disease, post streptococcal glomerulonephritis and invasive diseases 8 . In contrast, group C and G Streptococcus dysgalactiae subsp. equisimilis (GCS and GGS) were long considered to be commensal organisms that only rarely cause invasive infections as opportunistic pathogens.
Since the mid-1980s there has been a marked increase in reported invasive group A infections, including cases of STSS in Europe and North America 15, 33, 57 .
These fulminant infections were characterized by acute hypotension, shock, multiorgan impairment and death. However, the factors underlying the worldwide resurgence of this pathogen remain unknown 16 . In 1996, Vandamme et al 62 .
proposed that a novel subspecies, S. dysgalactiae subsp. equisimilis (SDSE), was a clinically significant pathogen. This microorganism possesses group C or G antigens (rarely A or L), and exhibits strong ␤-hemolysis.
Beginning around the year 2000, invasive infections such as bacteremia caused by SDSE as well as those caused by GAS and GBS 6, 12, 38, 59 have been increasingly reported worldwide. M proteins of GAS, which are encoded by emm genes and form elongated structures on the bacterial surface, play an important role in the pathogenesis of this microorganism. M proteins are known to be critical antiphagocytic constituents of GAS due to their role in resistance to opsonization 4, 14 . GCS and GGS have shown a similar pathogenic pattern to S. pyogenes 21 , coincidently expressing homologs of the M virulence proteins of S. pyogenes 7 . Moreover, some strains contain superantigen genes firstly characterized in S. pyogenes 25, 29 . As with the emm genes of S. pyogenes, GCS and GGS homologs have been used for sequence-based typing 3, 17, 25 . We conducted a prospective study to assess the relative prevalence of SDSE versus GAS in invasive infections in Argentina during a twelve-month period. The objective of this study was to determine their epidemiological features, to explore the molecular characteristics of the infecting strains, to study their genetic diversity, virulence genes, antibiotic susceptibility and antibiotic resistance genes.
Materials and methods
All S. pyogenes and SDSE isolated from invasive infections in 28 centers of 16 Argentinean cities from July 1, 2011 to June 30, 2012 were studied.
A microbiologist from each hospital was required to complete a data sheet of the isolates. During the study period, each laboratory collected one isolate per patient in accordance with the case definition. Isolates were appropriately sent to the reference center where they were preserved in 300 l of sheep blood at −80
• C.
Definitions
Infections in deep tissues, blood, cerebrospinal fluid, or other liquids obtained by puncture, in which causative organisms were isolated from otherwise sterile samples, were defined as invasive infections. STSS was defined as an invasive infection due to the presence of a ␤-hemolytic streptococcus and causing hypotension and two or more of the following conditions: renal impairment, coagulopathy, liver abnormalities, acute respiratory distress syndrome, extensive tissue necrosis and erythematous rash 55 .
Identification
S. pyogenes and SDSE were identified according to the differentiating characteristics described by Ruoff et al 49 . Hemolysis was detected on 5% sheep blood Columbia agar and the observation of chains was performed in Gram smears prepared with drops of overnight cultures in thioglycolate broth. Conventional identification included the following tests: pyrrolidonyl-␤-naphthylamide hydrolysis (PYR), bacitracin susceptibility, cell morphology and Gram staining characteristics, Voges-Proskauer, arginine dihydrolase, esculin, starch, sorbitol and trehalose fermentation,␣-galactosidase and ␤-glucuronidase. PYR and bacitracin tests were performed by using Britania ® disks (Buenos Aires, Argentina). Sorbitol, trehalose, ␣-galactosidase and ␤-glucuronidase were tested by using DIATABS ® commercial tablets (Rosco, Taastrup, Denmark) according to the manufacturer's instructions. Voges-Proskauer, arginine dihydrolase, esculin, and starch tests were performed by standard methods. Moreover, identification was performed using API 20 Strep ® (Biomérieux Argentina). Identification and grouping were completed by using the latex agglutination method (Slidex Strepto kit ® , Biomérieux Argentina).
emm typing
GAS emm DNA fragment preparation was conducted according to the protocol of the Centers for Disease Control and Prevention (CDC) 9 . As specified by the CDC protocol, primers 1 and 2 were used for amplifying the N-terminal region of the emm gene [primer 1 was 5'-TATT(C/G) GCTTAGAAAATTAA-3', and primer 2 was 5'-GCAAGTTCTTCAGCTTGTTT-3']. The DNA amplicons were sent for DNA sequencing. The first 160 bases of the 5 end of the emm gene were compared with those in the CDC emm sequence database (http://www.cdc.gov/ ncidod/biotech/strep/strepblast.htm). An emm type showing more than 98% identity with a CDC reference strain was identified as that particular emm type.
PFGE analysis
All isolates were digested by SmaI (Promega, Madison, WI, USA). Pulsed field gel electrophoresis (PFGE) was carried out according to the previously described protocol 10 . The digested fragments of DNA were separated by agarose gel 1.2% (TBE 0.5X) in the CHEF-DR III System (BioRad, Hercules, CA, EE.UU.) for 22 h (0.5---40 s pulses at 6 V/cm, 120
• C). The genetic relationship between the bacterial strains was evaluated based on the levels of similarity among the SmaI PFGE patterns. A dendrogram was constructed using the unweighted-pair group method with arithmetic mean (UPGMA) algorithm using BioNumerics software version 6.0 (Applied Maths, Kortrijk, Belgium).
Superantigen (SAg) gene detection
The isolates were tested for the presence of SAg genes, including speA, speB, speC, speF, speG, speH, speI, speJ, ssa, and smeZ 25 .
Antimicrobial susceptibility tests
Disk diffusion tests were performed by the Bauer and Kirby method according to CLSI guidelines with 5% sheep blood Mueller---Hinton agar 11 . Testing disks containing penicillin (PEN 10 U), erythromycin (ERY 15 g), clindamycin (CLI 2 g), tetracycline (TET 30 g), ofloxacin (5 g), pefloxacin (5 g), norfloxacin (10 g) and levofloxacin (5 g) were from Britania ® Laboratories (Buenos Aires, Argentina). Incubation was performed at 35
• C for 24 h in ambient air. 
Phenotypic expression of MLS resistance
When performing the disk diffusion tests, blunting of the CLI inhibition zone near an ERY disk placed at 12 mm from the edge of the CLI disk, indicated an inducible type of resistance to macrolides, lincosamides, and streptogramin B (MLSB), while no blunting indicated the probability of the efflux-mediated M resistance phenotype (resistance only to 14-and 15-membered macrolides). Resistance to both CLI and ERY indicated a constitutive type of MLS B resistance 50 . 
Detection of different macrolide and tetracycline resistance genes

Results
Epidemiological, clinical and demographic characteristics of the patients with SDSE invasive disease
One hundred and eleven invasive infections due to groups A, C, or G ␤-hemolytic streptococci were recorded. Eighty eight of them (79.3%) were identified as S. pyogenes, 16(14.4%) as GGS and 7(6.3%) as GCS. The annual prevalence in Argentina (2011---2012) was of at least 23 SDSE invasive infections. Most cases of SDSE invasive infections (65.2%) were diagnosed in Buenos Aires City and its surroundings (n: 9 cases in Ciudad Autónoma de Buenos Aires, n: 4 in San Martín, and n: 2 in Lanús). The rest of the cases were detected in Mar del Plata (2), Bahía Blanca (1), General Pico (La Pampa) (2), Santa Fe (2) and Concordia (Entre Ríos) (1). STSS was recorded in 11 cases (9 GAS, 1 SDSE group C and 1 SDSE group G) and mortality was 6.3% (4 adults and 1 child died as a consequence of a S. pyogenes infection and 2 adults died of GGS SDSE infections).
Most of the SDSE isolates were obtained from blood (60.9%). Other foci of infection were osteoarticular (21.7%) and soft tissue (17.4%). Only GAS was isolated from pleural effusion (n: 5) and ascites (n: 3).
The total number of patients was 111. Fifty-four of them were adults (≥16 years old) and fifty-seven were children (<16 years old). With regard to invasive infections by SDSE, nineteen patients were adults and four were children. The median age of the patients was 54 years old (20 months---90 years old) and 69.6% of the patients were male.
Almost 70% (69.6%) of the infected patients presented at least one predisposing condition and 17.4% more than one. The most frequent predisposing conditions for invasive disease were diabetes (n: 4), renal disease (n: 2), arterial hypertension (n: 2) and HIV infection (n: 2).
More than 80% (82.6%) of the patients had been treated with antibiotics. Clindamycin was only administered to 5 patients whereas immunoglobulins were not administered at all. None of the patients who died were treated with clindamycin.
Phenotypic identification
All GCS and GGS isolates obtained from invasive infections (n: 21) were identified by conventional biochemical tests and API20 Strep. Fourteen of them were isolated from blood, 3 from soft tissue, 2 from bone and 2 from joint-bone fluid. Table 1 shows the results of the manual biochemical tests and Table 2 Six distinct biochemical profiles were obtained using the API 20 Strep identification system: 19% of the strains fermented lactose and the same percentage hydrolyzed esculin, 86% fermented ribose and only 5% fermented glycogen.
Genetic diversity
A total of 23 isolates, 16 GGS and 7 GCS were isolated from invasive infections and 11 different emm genes were identified. Three types, stG62647 (n: 4), stG840 (n: 3) and stG653 (n: 3) predominated among the 21 emm invasive strains typed. Figure 1 shows the distribution of invasive types. The comparison with the types found in the 1998---1999 Argentinean multicenter study is also shown. All the sequences were compared with the CDC emm-sequence-database.
Nineteen distinct PFGE patterns were detected, with no significant relationship among them. The PFGE profiles of invasive strains digested with the restriction enzyme SmaI are shown in Figure 2 . Strains 11, 13 and 18 exhibited the same pattern and all were stG62647 type.
Virulence factors
Toxigenic genes speA, speB, speC, speF, speG, speH, speJ, smeZ and ssa were analyzed. All the strains only carried speJ and ssa genes simultaneously.
Antibiotic susceptibility and macrolide and tetracycline resistance gene study
All SDSE isolates showed in vitro susceptibility to PEN (MIC 90 0.016 g/ml) and to LEV (MIC 90 0.5 g/ml).
The percentage of isolates not susceptible to CLI was 19.0% (MIC 90 0.25 g/ml), to ERY 26.1% (MIC 90 4 g/ml) and to TET 30.4% (MIC 90 32 g/ml).
Only one isolate was found to be less susceptible to NOR, PEF and OFL by the disk diffusion method (13 mm, 6 mm and 19 mm, respectively). Breakpoints were only available for ofloxacin 11 and 19 mm was inside the category of susceptibility. Table 3 summarizes the minimum inhibitory concentration (MIC) ranges, MIC 50 and MIC 90 values of antimicrobial agents for SDSE. 
Discussion
Invasive SDSE infections included sepsis with an unknown focus, cellulitis, septic arthritis, pneumonia, necrotizing fascitis, meningitis, infectious endocarditis, STSS, abscesses at sites other than skin, osteomyelitis, and others.
In our study most of the SDSE isolates were obtained from blood (n: 14). The rest of the isolates were obtained from bone, joint fluid or soft tissue (n: 7).
All our strains were correctly identified by both systems (manual and API 20 Strep) as SDSE. The correlation was excellent between the tests with ROSCO tablets (esculin, sorbitol, trehalose, ␣-galactosidase and ␤-glucuronidase) and the same biochemical tests in the API 20 Strep panel.
The frequency of invasive SDSE infection has increased in Asia 5, 38 , in Europe 19, 34, 36, 37, 48, 53, 54 , and in America 1,6,40 over the years. In particular, since 2003, the number of invasive SDSE infections, including STSS and severe soft tissue infection 22, 26, 44 , has gradually increased in Japan each year. By the year 2011 the Argentine population was 40.73 million inhabitants, therefore, the annual prevalence of SDSE invasive infections (n: 23) was at least 0.06/100,000 in Argentina during the 2011---2012 period. This prevalence seems to be lower than that recorded in a previous multicenter study conducted in 1998---1999, in which 27 invasive SDSE infections were reported during six-months; however, more health institutions participated in that study 40 . As for age distribution, a population-based surveillance carried out by Broyles et al. (n: 212) 6 found that most patients suffering from invasive diseases due to SDSE (59.0%) were adults under 65 years old. Moreover, Takahashi et al.  analyzed 286 SDSE infections from August 2006 to December  2009 60 and all patients with invasive infections were adults, often elderly (74.0%), and most of them with underlying diseases. Another investigation 58 also indicated that invasive SDSE infection (n = 42) mostly occurred in elderly adults (60---80 years old). Severe underlying conditions (i.e., diabetes mellitus, liver or renal dysfunction, and others) were associated with 85.7% of these invasive SDSE infections.
In our study, the age range was 21---86 years; 57.1% of the patients were adults older than 50 years old (12 out of 21 patients).
With regard to underlying diseases, in U.S. surveillance reports, 96.2% of patients with invasive infections possessed underlying medical conditions 13 . Similarly to the study by Sunaoshi et al. 58 , 69.9% of SDSE-infected patients in Argentina presented at least one underlying disease and 17.4% had more than one, being diabetes the most frequent one.
Concerning SDSE disease outcomes, the mortality rate in a Japanese study (12.7%) was similar to that previously described in Hong Kong and the United States (12 and 15%) 6, 60, 64 . In our series, the mortality rate due to SDSE invasive infections was 8.7% (2 cases) and both were adults. The same percentage corresponded to STSS cases. Three STSS cases and 3 deaths were recorded in a previous six-month Argentinean study 40 . Neither fatalities nor SDSE-mediated STSS were detected in children. SDSE-mediated STSS was a consequence of infections due to types stG840 and stG62647 and fatal infections were associated with stC74.a and stG62647.
The dominant emm types in Japan (stG6792 and stG485) were different from those in the United States (stG6, stG245, stG2078, and stG643). The geographical factor may not be the only cause accounting for such difference since both study periods differed in these studies (2002---2004 vs. 2006---2009 ) 6, 60 . The emm type stG6792 was the most frequently found in SDSE Japanese isolates (n: 65; 22.7%) and was more strongly related to poor outcome of SDSE diseases than other SDSE emm types 60 . Furthermore, those isolates displayed similar DNA profiles with PFGE suggesting the clonal expansion of a specific subpopulation of strains rather than the spread of distinct strains.
In another study 58 , 3 emm types, stG6792, stG485, and stG2078, predominated among the 42 invasive strains; strains having the same emm type showed uniform DNA profiles by PFGE. Moreover, previous reports described emm types and the DNA profiles by PFGE as variable among SDSE strains 22, 26 . In two other SDSE bacteremia studies carried out in the U.S. and Israel, stG485, stG6, stG245 and stG2078 types were the most frequently found 6, 12 .
In our study, 19 distinct DNA profiles by PFGE were detected, not having significant relationship among them. These results were expected because strains were not isolated in the context of an epidemic outbreak and were obtained from different geographic places. Predominant emm-types were stG62647 (n: 4), stG840 (n: 3) and stG653 (n: 3). stG6792 (n: 1), stG485 (n: 2) and stG2078 (n: 0) types were less represented in the present study, in contrast to the study conducted by Sunaoshi et al 58 . The types in this study were also different from those reported in the previous Argentinean multicenter study (1998) , in which stG6.0 (n: 6), stG480 (n: 5) and stG10.0 (n: 4) types 40 predominated. Therefore, emm typing is an excellent comparative epidemiological tool for the analysis of SDSE strains belonging to different geographical regions or from the same region but isolated at different times.
The complete genomic sequence of SDSE GGS 124 (stG480.0) isolated from patients with STSS (GenBank accession No. AP010935) have been recently determined. The genome size was 2.1 Mbp, and sequence coverage with GAS genomes was 61---63% identity 20 . Interestingly, many genes encoding virulence factors in GAS were identified in SDSE.
SDSE possesses many virulence factors shared with GAS 28 , such as M protein, streptolysin O, streptolysin S, streptokinase, fibronectin binding protein, collagen binding protein and DNase. They also exhibit homology in streptococcal inhibitor of complement (SIC). However, they do not possess certain virulence factors, such as some superantigens, cysteine protease (SPE-B) and the ABC operon 52 . However, it was reported that some strains of SDSE may contain superantigen genes, which were firstly characterized in S. pyogenes 25, 29 . It has been suggested that these factors were transmitted from GAS to SDSE species 30 . We analyzed speA, speB, speC, speF, speG, speH, speJ, smeZ and ssa genes. All the strains harbored only speJ and ssa genes simultaneously.
In the study by Ikebe et al. from Japan, all isolates were negative to speA, speB, speC, speH, speI, speJ, speL and speM, however, 12 out 16 isolates had the speG gene 26 . As shown in the present study and in previous reports, SDSE secretes only a few previously known superantigen exotoxins 23, 35, 46 . The clinical manifestations of STSS caused by SDSE are similar to EGA. speA, speB, and speC genes were not observed in our study although they are the most frequent detected exotoxins in S. pyogenes. Therefore, we suspect that not yet identified superantigen exotoxins or exoenzimes may exist, which could play an important role in the development of STSS caused by SDSE.
Although 60 years have passed since the introduction of PEN, ␤-hemolytic streptococci still continue being susceptible to this antibiotic, even though some S. agalactiae strains showed reduced susceptibility 32 . Macrolide, CLI and TET resistance has been a matter of real concern because of the development of ERY-resistant S. pyogenes outbreaks in Japan, Australia and several Europeans countries since the 70s 42, 51, 56 . Macrolide and TET resistance has been observed both in GAS and SDSE 31, 43 . SDSE isolates (n = 212) collected in a multicenter surveillance study by Broyles et al. 6 in the United States showed resistance rates of 28.8% to ERY, 4.2% to CLI, and 0.9% to fluoroquinolones. In Korea 39 , high frequency of the TET resistancemediating tet(S) gene was demonstrated (68.8%), while ERY, CLI, and chloramphenicol resistance rates were low (9.4, 3.1 and 9.4%, respectively) 61 . Of 231 SDSE isolates in the study by Takahashi et al. 60 , four harbored the mef(A) gene, and 13 and six isolates carried the erm(A) and erm(B) genes, respectively.
In our study, 19.0% were non-susceptible to CLI and 26.1% to ERY. Only one strain was resistant to ERY (iMLS B phenotype, ermTR positive) and no CLI constitutive resistance was detected in the previous multicenter study 40 . In our study, TET resistance was 30.4%. Tw o tetracyclineresistant strains only carried the tet(M) gen while five others carried both the tet(M) and tet(O) genes.
TET resistance was also common in SDSE during the 1998---1999 period in Argentina (33.3% in group C SDSE and 40% in group G SDSE) 40 . In such study, TET resistance was 40.7% and all TET resistant strains carried only the tet(M) gen.
In Portugal, a high rate of fluoroquinolone resistance (12%) was detected between 1998 and 2005 47 , although a previous study from Europe and the United States detected less than 1% resistance toward this group of antibiotics 2 . All our isolates were in vitro susceptible to LEV. Only one isolate (strain 9) was found to have reduced susceptibility to NOR, PEF and OFL.
Fluoroquinolones act by inhibition of bacterial DNA gyrase and DNA polymerase. The alterations of these enzymes were the prevalent mechanism of resistance in the Streptococcus genus 24 . The mutation in the gyrA subunits (gyrase DNA) and parC (DNA topoisomerase) are found in the so-called quinolone resistance determining regions (QRDR). The mechanisms involved in the small diameters observed by the disk diffusion test with strain 9 deserve to be further studied.
In the future, we should continue to survey invasive SDSE infections to further clarify the prevalence of infection, the study of new virulence factors, the distribution of emm types and to monitor antibiotic susceptibility rates in the Argentinean population.
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